Proton Pump Inhibitor Use, Hip Fracture and Change in Bone Density In Postmenopausal Women Results from the Women’s Health Initiative

BACKGROUND: Proton pump inhibitor (PPI) medications have been inconsistently shown to be associated with osteoporotic fractures. The objective was to examine the association of PPI use with bone outcomes (fracture, bone mineral density [BMD]) METHODS: This prospective analysis included 161,806 postm...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Arch Intern Med
Main Authors: Gray, Shelly L., LaCroix, Andrea Z., Larson, Joseph, Robbins, John, Cauley, Jane A., Manson, JoAnn E., Chen, Zhao
Formato: Artigo
Idioma:Inglês
Publicado: 2010
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4240017/
https://ncbi.nlm.nih.gov/pubmed/20458083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archinternmed.2010.94
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares